Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

We conducted a phase II trial to investigate the efficacy of concurrent chemoradiation in patients with stage III non-small-cell lung cancer (NSCLC). Thirty patients with inoperable NSCLC were enrolled onto a multicenter phase II trial of concurrent chemoradiation therapy. Patients received six week...

Saved in:

書目詳細資料
Main Authors:	Ratanatharathorn V., Lorvidhaya V., Maoleekoonpairoj S., Phromratanapongse P., Sirilerttrakul S., Kraipiboon P., Cheirsilpa A., Tangkaratt S., Srimuninnimit V., Pattaranutaporn P.
格式:	Article
語言:	English
出版:	2014
在線閱讀:	http://www.scopus.com/inward/record.url?eid=2-s2.0-0035139474&partnerID=40&md5=c3ed54527fb5051eb86c5935ab6f463f http://cmuir.cmu.ac.th/handle/6653943832/2006
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University
語言:	English

相似書籍

Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Phase II study of concurrent chemoradiotherapy for inoperable (Bulky) stage III (A/B) Non-Small Cell Lung Cancer (NSCLC) : A preliminary report
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Paclitaxel and Carboplatin in Combination in the Treatment of Advanced Non-small-cell Lung Cancer (NSCLC) : A Preliminary Study
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Effects of paclitaxel and carboplatin on quality of life and survival in patients with advanced non-small-cell lung cancer
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer
由: Chitapanarux I., et al.
出版: (2014)

Tolerability and efficacy of concurrent chemoradiotherapy comparing carboplatin/paclitaxel versus platinum/5-FU regimen for locally advanced esophageal and esophagogastric junction cancers
由: Amorn Tamtai, et al.
出版: (2018)

A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer
由: Imjai Chitapanarux, et al.
出版: (2018)

Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma
由: Wong, A.S.C., et al.
出版: (2011)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
由: Chitapanarux I., et al.
出版: (2014)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
由: I. Chitapanarux, et al.
出版: (2018)

Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
由: Charoentum C., et al.
出版: (2014)

Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
由: Chaiyut Charoentum, et al.
出版: (2018)

Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial
由: Lorvidhaya V., et al.
出版: (2014)

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
由: Tony S. Mok, et al.
出版: (2018)

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
由: Tony S. Mok, et al.
出版: (2018)

Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: Randomised, non-inferiority, open trial
由: Chitapanarux I., et al.
出版: (2014)

Adverse affects of paclitaxel and carboplatin combination chemotherapy in epithelial gynecologic cancer
由: Kietpeerakool C., et al.
出版: (2014)

Real-world evidence of cisplatin versus carboplatin in patients with locally advanced nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: A multicenter analysis
由: Arunee Dechaphunkul, et al.
出版: (2022)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Sumitra Thongprasert, et al.
出版: (2018)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Two-year outcome of concurrent chemoradiation with carboplatin with or without adjuvant carboplatin/fluorouracil in nasopharyngeal cancer: A multicenter randomized trial
由: Imjai Chitapanarux, et al.
出版: (2020)

Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial
由: Vicharn Lorvidhaya, et al.
出版: (2018)

Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
由: Lee, Matilda X, et al.
出版: (2021)

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid Tumors
由: Lee, Matilda Xinwei, et al.
出版: (2022)

Adverse affects of paclitaxel and carboplatin combination chemotherapy in epithelial gynecologic cancer
由: Chumnan Kietpeerakool, et al.
出版: (2018)

Remission of recurrent cervical cancer with paclitaxel and carboplatin: A case report and review of literature
由: W. Termrungruanglert, et al.
出版: (2018)

Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non - small-cell lung cancer in Asia (IPASS)
由: Fukuoka M., et al.
出版: (2017)

Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer
由: Kietpeerakool C., et al.
出版: (2014)

Symptom Clusters in Thai Gynecological Oncology Patients Receiving the First Cycle of Carboplatin and Paclitaxel
由: Bualuang Sumdaengrit, et al.
出版: (2022)

Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: Randomised, non-inferiority, open trial
由: Imjai Chitapanarux, et al.
出版: (2018)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin.
由: Sirichaisutdhikorn D., et al.
出版: (2014)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin
由: Sirichaisutdhikorn D., et al.
出版: (2014)

The Comparison of Neutropenia and Peripheral Neuropathy Condition as an Impact of 3-hours and 24-hour Paclitaxel Infusion of Paclitaxel-Carboplatin Chemotherapy on Ovarian Cancer Patients
由: Primandono Perbowo, -, et al.
出版: (2019)

Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer
由: Chumnan Kietpeerakool, et al.
出版: (2018)

Real-world evidence of cisplatin versus carboplatin in patients with locally advanced nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: A multicenter analysis
由: Dechaphunkul A.
出版: (2023)

A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer
由: Sumitra Thongprasert, et al.
出版: (2018)

Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy
由: Chumnan Kietpeerakool, et al.
出版: (2018)

Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy
由: Chumnan Kietpeerakool, et al.
出版: (2018)